Prostacycline Vasodilator [EPC]

Prostacycline Vasodilator [EPC] was reported 137818 times

Drugs of the Prostacycline Vasodilator [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DEVICE WIRELESS COMMUNICATION ISSUE 256 0.9884
1 INFUSION SITE PUSTULE 111 0.8672
2 DEVICE MAINTENANCE ISSUE 471 0.8010
3 CATHETER SITE PRURITUS 665 0.7574
4 CATHETER MANAGEMENT 662 0.7364
5 UNEVALUABLE DEVICE ISSUE 65 0.7303
6 CATHETER SITE SCAB 77 0.7196
7 INFUSION SITE INFECTION 1558 0.6698
8 BENDOPNOEA 147 0.6682
9 CATHETER SITE VESICLES 129 0.6615
10 CATHETER SITE RASH 284 0.6283
11 CATHETER SITE IRRITATION 205 0.6156
12 ADMINISTRATION SITE ODOUR 46 0.6053
13 INFUSION SITE SCAB 69 0.5610
14 INFUSION SITE DISCHARGE 949 0.5407
15 CATHETER SITE DISCHARGE 589 0.5240
16 CATHETER SITE ERYTHEMA 1053 0.4916
17 CATHETER SITE WARMTH 80 0.4908
18 INFUSION SITE WARMTH 601 0.4902
19 INTRACARDIAC PRESSURE INCREASED 43 0.4886
20 CATHETER SITE DISCOLOURATION 58 0.4754
21 INFUSION SITE IRRITATION 604 0.4700
22 INFUSION SITE CELLULITIS 243 0.4602
23 INFUSION SITE INJURY 81 0.4602
24 INFUSION SITE PAIN 5825 0.4516
25 INFUSION SITE INDURATION 662 0.4464
26 INFUSION SITE HAEMORRHAGE 1452 0.4409
27 OXYGEN CONSUMPTION INCREASED 1034 0.4323
28 INFUSION SITE OEDEMA 357 0.4270
29 PATIENT DISSATISFACTION WITH DEVICE 107 0.4246
30 TRANSPLANT EVALUATION 215 0.4232
31 WALKING DISTANCE TEST ABNORMAL 162 0.4143
32 INFUSION SITE INFLAMMATION 286 0.4051
33 INFUSION SITE ERYTHEMA 3410 0.4041
34 INFUSION SITE ABSCESS 203 0.4028
35 INFUSION SITE VESICLES 205 0.3897
36 HEART AND LUNG TRANSPLANT 49 0.3798
37 PULMONARY ARTERIAL HYPERTENSION 5440 0.3750
38 DEVICE INFUSION ISSUE 905 0.3646
39 CATHETER SITE SWELLING 335 0.3579
40 VASCULAR DEVICE OCCLUSION 119 0.3510
41 INFUSION SITE DISCOLOURATION 306 0.3477
42 ACUTE RIGHT VENTRICULAR FAILURE 59 0.3471
43 PULMONARY ARTERIAL PRESSURE ABNORMAL 99 0.3438
44 PULMONARY ARTERIAL PRESSURE INCREASED 553 0.3393
45 DEVICE ALARM ISSUE 612 0.3368
46 CATHETER SITE PAIN 861 0.3315
47 PULMONARY HYPERTENSIVE CRISIS 86 0.3173
48 POST-TUSSIVE VOMITING 51 0.3129
49 CATHETERISATION CARDIAC ABNORMAL 84 0.3111
50 CATHETER SITE INFLAMMATION 175 0.3108
51 INFUSION SITE SWELLING 1953 0.3100
52 RIGHT VENTRICULAR FAILURE 2107 0.3004
53 INFUSION SITE NODULE 284 0.2955
54 INFUSION SITE DISCOMFORT 302 0.2912
55 CARDIAC FAILURE HIGH OUTPUT 66 0.2739
56 CATHETER SITE HAEMORRHAGE 661 0.2640
57 INFUSION SITE RASH 352 0.2564
58 INFUSION SITE PRURITUS 798 0.2527
59 CARDIAC OUTPUT INCREASED 43 0.2515
60 VASCULAR DEVICE INFECTION 1135 0.2499
61 COR PULMONALE CHRONIC 45 0.2394
62 CATHETER SITE EXTRAVASATION 95 0.2381
63 VENTILATION PERFUSION MISMATCH 66 0.2349
64 PULMONARY VENO-OCCLUSIVE DISEASE 162 0.2314
65 PARACENTESIS 138 0.2244
66 CATHETER PLACEMENT 409 0.2204
67 DIZZINESS EXERTIONAL 167 0.2197
68 INFUSION SITE REACTION 654 0.2187
69 CATHETER REMOVAL 78 0.2185
70 INFUSION SITE SCAR 94 0.2122
71 CATHETER SITE CELLULITIS 57 0.1945
72 DERMATITIS CONTACT 2099 0.1839
73 PAIN IN JAW 5167 0.1822
74 CATHETER SITE RELATED REACTION 133 0.1773
75 LUNG TRANSPLANT 623 0.1758
76 DEVICE RELATED SEPSIS 354 0.1757
77 DEVICE PROGRAMMING ERROR 55 0.1735
78 DYSPNOEA AT REST 489 0.1686
79 CENTRAL VENOUS CATHETERISATION 509 0.1686
80 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 53 0.1672
81 CATHETER SITE INFECTION 615 0.1624
82 PULMONARY HYPERTENSION 3347 0.1605
83 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 90 0.1604
84 DEVICE CONNECTION ISSUE 338 0.1600
85 MEDICAL DEVICE CHANGE 84 0.1576
86 HYPERVOLAEMIA 772 0.1561
87 DEVICE ELECTRICAL FINDING 109 0.1540
88 RIGHT VENTRICULAR DYSFUNCTION 162 0.1469
89 FLUID OVERLOAD 2126 0.1459
90 SCLERODERMA 515 0.1416
91 DEVICE RELATED INFECTION 2127 0.1380
92 INFUSION SITE MASS 150 0.1380
93 DYSPNOEA EXERTIONAL 5138 0.1363
94 DEVICE DAMAGE 105 0.1317
95 SEASONAL ALLERGY 1801 0.1271
96 RIGHT VENTRICULAR DILATATION 71 0.1226
97 DEVICE POWER SOURCE ISSUE 353 0.1208
98 INFUSION SITE HAEMATOMA 57 0.1197
99 SUTURE RELATED COMPLICATION 84 0.1188
100 FLUID RETENTION 5898 0.1158
101 ABDOMINAL CAVITY DRAINAGE 48 0.1137
102 CATHETERISATION CARDIAC 479 0.1079
103 INJECTION SITE INFECTION 351 0.1067
104 THROMBOSIS IN DEVICE 345 0.1052
105 COR PULMONALE 100 0.1047
106 DRUG TOLERANCE DECREASED 293 0.1042
107 HAEMOGLOBIN INCREASED 462 0.1012
108 INFUSION SITE BRUISING 214 0.0990
109 RESPIRATORY TRACT IRRITATION 103 0.0987
110 DRUG TITRATION ERROR 253 0.0979
111 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 96 0.0953
112 OXYGEN SATURATION DECREASED 5330 0.0947
113 PURULENT DISCHARGE 404 0.0945
114 CENTRAL VENOUS CATHETER REMOVAL 44 0.0938
115 CHRONIC RESPIRATORY FAILURE 112 0.0927
116 SUTURE RUPTURE 63 0.0909
117 INJECTION SITE DISCHARGE 486 0.0903
118 SICKLE CELL ANAEMIA 57 0.0884
119 PATIENT DISSATISFACTION WITH TREATMENT 160 0.0829
120 DEVICE RELATED THROMBOSIS 80 0.0811
121 JUGULAR VEIN DISTENSION 46 0.0811
122 OXYGEN SATURATION ABNORMAL 225 0.0792
123 NOCTURNAL DYSPNOEA 101 0.0792
124 INFUSION SITE URTICARIA 53 0.0791
125 ASPIRATION PLEURAL CAVITY 60 0.0780
126 ECHOCARDIOGRAM ABNORMAL 107 0.0764
127 RESPIRATION ABNORMAL 497 0.0720
128 PULMONARY PAIN 205 0.0702
129 CARBON DIOXIDE INCREASED 94 0.0689
130 DEVICE OCCLUSION 960 0.0681
131 BRAIN NATRIURETIC PEPTIDE INCREASED 209 0.0677
132 LOCALISED OEDEMA 311 0.0671
133 DIZZINESS POSTURAL 647 0.0667
134 ADMINISTRATION SITE PAIN 74 0.0642
135 THERAPY NON-RESPONDER 2858 0.0635
136 EXERCISE TOLERANCE DECREASED 353 0.0613
137 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 86 0.0612
138 PRODUCT AFTER TASTE 57 0.0597
139 HYPOXIA 2090 0.0593
140 WRONG DOSE 138 0.0570
141 OXYGEN THERAPY 90 0.0547
142 THROAT IRRITATION 2452 0.0546
143 PNEUMONIA INFLUENZAL 64 0.0537
144 THERAPY CHANGE 528 0.0536
145 BLOOD PRESSURE SYSTOLIC DECREASED 239 0.0525
146 RHINOVIRUS INFECTION 204 0.0524
147 CARDIAC OUTPUT DECREASED 46 0.0521
148 OEDEMA 2793 0.0514
149 RALES 295 0.0507
150 BLOOD CULTURE POSITIVE 152 0.0507
151 COMPLICATION ASSOCIATED WITH DEVICE 736 0.0506
152 DEVICE DISLOCATION 2167 0.0498
153 CHOKING SENSATION 273 0.0495
154 PRODUCT ADMINISTRATION INTERRUPTED 388 0.0494
155 CARDIAC ABLATION 88 0.0492
156 INJECTION SITE SCAB 47 0.0488
157 PRODUCTIVE COUGH 2325 0.0487
158 DEVICE FAILURE 734 0.0482
159 RESPIRATORY TRACT CONGESTION 764 0.0480
160 NASAL CONGESTION 2798 0.0476
161 FLUSHING 4819 0.0474
162 PARANASAL SINUS HYPERSECRETION 177 0.0463
163 HAEMOPTYSIS 1287 0.0461
164 TRANSFUSION 475 0.0453
165 INFUSION SITE EXTRAVASATION 281 0.0451
166 PERICARDIAL EFFUSION 1024 0.0442
167 MIDDLE EAR EFFUSION 97 0.0439
168 PAINFUL RESPIRATION 105 0.0435
169 VASODILATATION 109 0.0432
170 PRODUCT LEAKAGE 239 0.0425
171 COUGH 11821 0.0421
172 ACUTE RESPIRATORY FAILURE 810 0.0421
173 DYSPNOEA 23704 0.0418
174 PARANASAL SINUS DISCOMFORT 158 0.0417
175 INCORRECT DRUG ADMINISTRATION RATE 177 0.0415
176 INTRA-ABDOMINAL FLUID COLLECTION 74 0.0413
177 STAPHYLOCOCCUS TEST POSITIVE 87 0.0412
178 PRODUCT DEPOSIT 63 0.0404
179 MECHANICAL VENTILATION 75 0.0394
180 DEVICE PHYSICAL PROPERTY ISSUE 301 0.0392
181 EAR CONGESTION 106 0.0391
182 ASCITES 1138 0.0387
183 ORTHOPNOEA 120 0.0376
184 ATRIAL FLUTTER 297 0.0372
185 PRESYNCOPE 905 0.0372
186 CARDIAC DISCOMFORT 73 0.0362
187 LOWER RESPIRATORY TRACT CONGESTION 61 0.0358
188 CARDIOVERSION 50 0.0358
189 LIVER TRANSPLANT 130 0.0357
190 EPISTAXIS 2658 0.0355
191 SINUS CONGESTION 468 0.0346
192 NASAL DRYNESS 216 0.0344
193 SPUTUM DISCOLOURED 323 0.0340
194 HAEMATOLOGICAL INFECTION 83 0.0339
195 TRANSPLANT 80 0.0337
196 OEDEMA PERIPHERAL 4106 0.0337
197 TRACHEOSTOMY 48 0.0336
198 EMERGENCY CARE 99 0.0326
199 BREATH SOUNDS ABNORMAL 159 0.0322
200 ENDOTRACHEAL INTUBATION 90 0.0321
201 HYPOTENSION 6389 0.0318
202 WEIGHT FLUCTUATION 331 0.0316
203 SECRETION DISCHARGE 395 0.0315
204 SYNCOPE 3149 0.0314
205 SINUS DISORDER 621 0.0313
206 CARDIAC FAILURE ACUTE 208 0.0312
207 DRUG DOSE TITRATION NOT PERFORMED 57 0.0311
208 IDIOPATHIC PULMONARY FIBROSIS 123 0.0311
209 DEVICE LEAKAGE 1341 0.0309
210 RESPIRATORY TRACT INFECTION VIRAL 72 0.0309
211 PULMONARY OEDEMA 1384 0.0309
212 HEADACHE 19074 0.0304
213 DEVICE KINK 110 0.0302
214 RETCHING 643 0.0301
215 INJECTION SITE CELLULITIS 55 0.0296
216 DECREASED ACTIVITY 318 0.0294
217 BACTERAEMIA 347 0.0292
218 THERAPY PARTIAL RESPONDER 455 0.0291
219 DEVICE PLACEMENT ISSUE 104 0.0290
220 BLOOD PRESSURE DECREASED 1927 0.0290
221 CHEST PAIN 5289 0.0285
222 CHEST DISCOMFORT 2917 0.0285
223 MEDICAL DEVICE COMPLICATION 208 0.0281
224 DEVICE OPERATIONAL ISSUE 121 0.0281
225 SENSITIVITY TO WEATHER CHANGE 148 0.0281
226 OROPHARYNGEAL DISCOMFORT 253 0.0280
227 SINUS HEADACHE 166 0.0279
228 DYSENTERY 52 0.0279
229 INJECTION SITE OEDEMA 48 0.0279
230 FAECES SOFT 200 0.0275
231 BLOOD IRON DECREASED 321 0.0270
232 PNEUMONIA VIRAL 86 0.0270
233 UPPER-AIRWAY COUGH SYNDROME 219 0.0266
234 INTERNAL HAEMORRHAGE 297 0.0260
235 PALPITATIONS 3028 0.0258
236 DISEASE COMPLICATION 118 0.0258
237 BLOOD POTASSIUM DECREASED 768 0.0255
238 EAR DISCOMFORT 261 0.0254
239 DRY THROAT 257 0.0253
240 GOUT 450 0.0251
241 SINUS PAIN 58 0.0249
242 BLOOD LOSS ANAEMIA 56 0.0247
243 EYE CONTUSION 52 0.0246
244 DIARRHOEA 15707 0.0243
245 HEAD DISCOMFORT 428 0.0242
246 CARDIAC FLUTTER 156 0.0241
247 LEFT VENTRICULAR FAILURE 83 0.0241
248 GASTROENTERITIS VIRAL 433 0.0240
249 CARDIAC FAILURE 1902 0.0237
250 COLONOSCOPY 52 0.0236
251 OROPHARYNGEAL PAIN 2185 0.0236
252 RESPIRATORY SYNCYTIAL VIRUS INFECTION 205 0.0235
253 CLOSTRIDIUM DIFFICILE INFECTION 513 0.0235
254 TERMINAL STATE 157 0.0235
255 LUNG DISORDER 1147 0.0234
256 PHYSICAL DECONDITIONING 60 0.0233
257 BLOOD POTASSIUM ABNORMAL 62 0.0232
258 RESPIRATORY FAILURE 1694 0.0232
259 WEIGHT ABNORMAL 55 0.0229
260 HEART RATE INCREASED 2253 0.0227
261 PERIPHERAL SWELLING 3502 0.0227
262 DEVICE ISSUE 2014 0.0224
263 STAPHYLOCOCCAL BACTERAEMIA 96 0.0221
264 CYANOSIS 346 0.0220
265 ATRIAL TACHYCARDIA 46 0.0219
266 PULMONARY HAEMORRHAGE 171 0.0218
267 UNINTENTIONAL MEDICAL DEVICE REMOVAL 250 0.0216
268 BLOOD PRESSURE ABNORMAL 426 0.0214
269 FINE MOTOR SKILL DYSFUNCTION 62 0.0214
270 DEVICE INFORMATION OUTPUT ISSUE 165 0.0212
271 HEART RATE ABNORMAL 117 0.0210
272 HAEMATOCRIT INCREASED 47 0.0206
273 SUPRAVENTRICULAR TACHYCARDIA 196 0.0205
274 DIZZINESS 10148 0.0203
275 RESPIRATORY DISTRESS 558 0.0202
276 HYPOPNOEA 70 0.0201
277 HAEMORRHOIDAL HAEMORRHAGE 98 0.0200
278 ABDOMINAL DISTENSION 2094 0.0200
279 PNEUMONIA 6474 0.0200
280 HYPERCAPNIA 60 0.0199
281 GASTRIC INFECTION 76 0.0198
282 FOOD POISONING 106 0.0198
283 SARCOIDOSIS 94 0.0198
284 PULSELESS ELECTRICAL ACTIVITY 82 0.0196
285 DEVICE USE ERROR 677 0.0195
286 CARDIOGENIC SHOCK 279 0.0194
287 CARDIAC FAILURE CONGESTIVE 1554 0.0193
288 UPPER RESPIRATORY TRACT CONGESTION 56 0.0193
289 PAIN IN EXTREMITY 5660 0.0192
290 CREPITATIONS 57 0.0191
291 SKIN ABRASION 89 0.0188
292 SLUGGISHNESS 192 0.0188
293 RHINORRHOEA 1205 0.0186
294 VIRAL INFECTION 613 0.0184
295 CHOLECYSTITIS INFECTIVE 51 0.0184
296 DEVICE MALFUNCTION 1277 0.0182
297 CELLULITIS 910 0.0180
298 PNEUMOTHORAX 285 0.0180
299 PULMONARY FIBROSIS 344 0.0179
300 CARDIOMEGALY 220 0.0179
301 TREATMENT NONCOMPLIANCE 978 0.0179
302 NAUSEA 14065 0.0178
303 COVID-19 PNEUMONIA 207 0.0175
304 PORTAL HYPERTENSION 54 0.0175
305 INJECTION SITE IRRITATION 222 0.0174
306 GENERALISED OEDEMA 215 0.0174
307 ENDOCARDITIS 89 0.0173
308 THROAT CLEARING 65 0.0173
309 ABDOMINAL DISCOMFORT 2900 0.0173
310 NASOPHARYNGITIS 3164 0.0171
311 DECREASED APPETITE 3956 0.0170
312 NASAL DISCOMFORT 135 0.0170
313 HERNIA REPAIR 44 0.0169
314 AMMONIA INCREASED 86 0.0168
315 THERAPY CESSATION 863 0.0168
316 LOCALISED INFECTION 405 0.0167
317 PLEURAL EFFUSION 1019 0.0167
318 HEART RATE IRREGULAR 377 0.0167
319 CARDIAC FAILURE CHRONIC 71 0.0166
320 FACE INJURY 63 0.0166
321 INTERNATIONAL NORMALISED RATIO ABNORMAL 57 0.0166
322 HEAD INJURY 521 0.0164
323 STAPHYLOCOCCAL INFECTION 542 0.0164
324 CONCOMITANT DISEASE AGGRAVATED 101 0.0163
325 GASTROINTESTINAL MOTILITY DISORDER 87 0.0162
326 WEIGHT DECREASED 4533 0.0162
327 DYSPEPSIA 1596 0.0162
328 HAEMODYNAMIC INSTABILITY 123 0.0161
329 SKIN INFECTION 181 0.0161
330 UPPER RESPIRATORY TRACT INFECTION 745 0.0161
331 DEVICE BREAKAGE 652 0.0160
332 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 836 0.0160
333 MUSCLE STRAIN 138 0.0159
334 CARDIOPULMONARY FAILURE 61 0.0156
335 MUSCULOSKELETAL CHEST PAIN 242 0.0156
336 POLYURIA 128 0.0156
337 INTERNATIONAL NORMALISED RATIO DECREASED 63 0.0155
338 DEVICE USE ISSUE 272 0.0155
339 PULMONARY THROMBOSIS 169 0.0155
340 VOMITING 7274 0.0155
341 BLOOD MAGNESIUM DECREASED 133 0.0154
342 IRON DEFICIENCY ANAEMIA 142 0.0154
343 DIALYSIS 217 0.0153
344 STAPHYLOCOCCAL SEPSIS 75 0.0152
345 SWELLING 1416 0.0151
346 TRISMUS 78 0.0151
347 BRONCHITIS 1116 0.0151
348 DRUG INTOLERANCE 1452 0.0150
349 SNEEZING 336 0.0150
350 PRODUCT LABEL CONFUSION 87 0.0149
351 FLANK PAIN 138 0.0147
352 MIGRAINE 1403 0.0147
353 INFLUENZA 1636 0.0147
354 HEART VALVE INCOMPETENCE 42 0.0146
355 FEELING ABNORMAL 3506 0.0146
356 CARDIAC DYSFUNCTION 54 0.0145
357 FACIAL PAIN 129 0.0144
358 CARDIAC PACEMAKER INSERTION 86 0.0144
359 MALAISE 6327 0.0144
360 ATRIAL FIBRILLATION 1395 0.0143
361 UNEVALUABLE EVENT 1080 0.0143
362 SEPSIS 1592 0.0143
363 URINE OUTPUT DECREASED 124 0.0142
364 EAR INFECTION 377 0.0142
365 HYPERSOMNIA 406 0.0141
366 STENT PLACEMENT 114 0.0141
367 ANAL INCONTINENCE 127 0.0141
368 VIRAL UPPER RESPIRATORY TRACT INFECTION 67 0.0141
369 RESPIRATORY TRACT INFECTION 366 0.0140
370 FEELING OF BODY TEMPERATURE CHANGE 82 0.0140
371 NON-CARDIAC CHEST PAIN 44 0.0139
372 LOSS OF CONSCIOUSNESS 1776 0.0138
373 PULMONARY CONGESTION 182 0.0138
374 TRICUSPID VALVE INCOMPETENCE 109 0.0137
375 GASTROINTESTINAL DISORDER 1227 0.0137
376 PRODUCT DISTRIBUTION ISSUE 126 0.0136
377 POST PROCEDURAL COMPLICATION 260 0.0135
378 OESOPHAGEAL DISORDER 52 0.0135
379 GASTROINTESTINAL HAEMORRHAGE 1125 0.0134
380 NECK PAIN 751 0.0134
381 DEHYDRATION 1789 0.0134
382 SINUSITIS 1371 0.0134
383 DRUG DOSE OMISSION 2204 0.0133
384 FATIGUE 10376 0.0133
385 RESPIRATORY RATE INCREASED 118 0.0133
386 FAILURE TO THRIVE 69 0.0133
387 ILLNESS 1368 0.0133
388 SENSITIVE SKIN 97 0.0131
389 MENTAL STATUS CHANGES 365 0.0131
390 FLATULENCE 740 0.0130
391 CARDIAC OPERATION 112 0.0130
392 HYPOVOLAEMIA 76 0.0130
393 RESTLESS LEGS SYNDROME 235 0.0129
394 GASTRIC DISORDER 443 0.0129
395 GASTROOESOPHAGEAL REFLUX DISEASE 1037 0.0129
396 ASTHENIA 4843 0.0129
397 HEPATIC CIRRHOSIS 242 0.0129
398 CARDIAC TAMPONADE 61 0.0128
399 PULMONARY ALVEOLAR HAEMORRHAGE 72 0.0128
400 FEELING COLD 355 0.0127
401 WHEEZING 756 0.0127
402 DYSPHONIA 736 0.0126
403 MULTIPLE ALLERGIES 98 0.0125
404 ABDOMINAL PAIN UPPER 2573 0.0125
405 BRONCHOSPASM 178 0.0125
406 ABNORMAL LOSS OF WEIGHT 85 0.0125
407 HAEMATEMESIS 315 0.0124
408 LIMB INJURY 334 0.0123
409 HOSPITALISATION 1888 0.0123
410 FAECES DISCOLOURED 265 0.0122
411 ELECTROLYTE IMBALANCE 142 0.0122
412 BRAIN FOG 191 0.0122
413 GALLBLADDER DISORDER 216 0.0121
414 TENSION HEADACHE 52 0.0121
415 CANDIDA INFECTION 204 0.0121
416 SKIN LACERATION 131 0.0120
417 WEIGHT INCREASED 2695 0.0120
418 RENAL DISORDER 557 0.0119
419 HIP FRACTURE 383 0.0119
420 EAR PAIN 231 0.0119
421 PALLOR 323 0.0119
422 DEATH 10213 0.0118
423 INTERNATIONAL NORMALISED RATIO INCREASED 338 0.0118
424 MUSCULOSKELETAL DISCOMFORT 204 0.0118
425 MYALGIA 2009 0.0118
426 BACTERIAL INFECTION 220 0.0118
427 IRON DEFICIENCY 53 0.0118
428 PHARYNGITIS STREPTOCOCCAL 127 0.0117
429 TASTE DISORDER 238 0.0117
430 FEELING JITTERY 223 0.0117
431 LUNG INFECTION 181 0.0116
432 FRUSTRATION TOLERANCE DECREASED 94 0.0116
433 PRODUCT USE COMPLAINT 183 0.0116
434 NEURALGIA 282 0.0116
435 CARDIAC DISORDER 1083 0.0116
436 HOSPICE CARE 114 0.0115
437 FEEDING DISORDER 234 0.0115
438 POOR PERIPHERAL CIRCULATION 49 0.0115
439 INTENTIONAL DOSE OMISSION 327 0.0115
440 BLOOD PRESSURE DIASTOLIC DECREASED 84 0.0114
441 PROCEDURAL COMPLICATION 87 0.0113
442 TOOTHACHE 205 0.0113
443 COMPRESSION FRACTURE 60 0.0112
444 MOUTH HAEMORRHAGE 82 0.0112
445 DRUG DELIVERY SYSTEM MALFUNCTION 57 0.0111
446 REHABILITATION THERAPY 43 0.0111
447 RESPIRATORY DISORDER 332 0.0111
448 PNEUMONIA BACTERIAL 101 0.0110
449 FREQUENT BOWEL MOVEMENTS 297 0.0110
450 FEELING HOT 674 0.0110
451 LIMB DISCOMFORT 338 0.0109
452 BACK PAIN 2536 0.0109
453 INCREASED UPPER AIRWAY SECRETION 56 0.0109
454 INJECTION SITE VESICLES 66 0.0109
455 LETHARGY 626 0.0109
456 POST PROCEDURAL HAEMORRHAGE 126 0.0108
457 GENERAL PHYSICAL HEALTH DETERIORATION 1252 0.0108
458 APHONIA 151 0.0108
459 MUSCULOSKELETAL PAIN 563 0.0107
460 PULMONARY FUNCTION TEST DECREASED 47 0.0107
461 DISEASE PROGRESSION 1263 0.0107
462 BLOOD SODIUM DECREASED 201 0.0107
463 CHILLS 1248 0.0106
464 BLOOD COUNT ABNORMAL 161 0.0106
465 JAW DISORDER 58 0.0106
466 CONDITION AGGRAVATED 3212 0.0106
467 FALL 3511 0.0105
468 GASTRIC HAEMORRHAGE 121 0.0105
469 POOR QUALITY SLEEP 226 0.0105
470 COLD SWEAT 184 0.0104
471 TOOTH INFECTION 137 0.0104
472 GASTROINTESTINAL INFECTION 93 0.0104
473 HERNIA 200 0.0103
474 HAEMOGLOBIN DECREASED 1054 0.0103
475 PRODUCT USE ISSUE 1926 0.0102
476 PRODUCT RESIDUE PRESENT 55 0.0102
477 HYPERVENTILATION 59 0.0102
478 CARDIAC VALVE DISEASE 58 0.0101
479 KIDNEY INFECTION 199 0.0101
480 HEART RATE DECREASED 356 0.0101
481 TONGUE DISCOMFORT 43 0.0101
482 MUCOUS STOOLS 50 0.0101
483 AUTOIMMUNE DISORDER 98 0.0100
484 TOOTH ABSCESS 102 0.0100
485 ERUCTATION 193 0.0100
486 SICKLE CELL ANAEMIA WITH CRISIS 157 0.0100
487 ULCER HAEMORRHAGE 67 0.0099
488 ARTHROPOD BITE 73 0.0098
489 INFECTION 1424 0.0098
490 INTERSTITIAL LUNG DISEASE 475 0.0098
491 ACCIDENTAL OVERDOSE 354 0.0097
492 BLOOD POTASSIUM INCREASED 157 0.0097
493 BLOOD PRESSURE FLUCTUATION 232 0.0097
494 TACHYCARDIA 857 0.0096
495 SYSTEMIC LUPUS ERYTHEMATOSUS 342 0.0096
496 PELVIC FRACTURE 75 0.0096
497 DEAFNESS UNILATERAL 53 0.0096
498 PERIPHERAL COLDNESS 132 0.0096
499 RIB FRACTURE 197 0.0096
500 SUBDURAL HAEMATOMA 137 0.0096
501 ORAL CANDIDIASIS 126 0.0096
502 MUSCLE TIGHTNESS 155 0.0096
503 CLOSTRIDIUM DIFFICILE COLITIS 101 0.0095
504 GINGIVAL BLEEDING 130 0.0095
505 BACK INJURY 103 0.0095
506 DRY MOUTH 768 0.0095
507 HAEMATOCHEZIA 520 0.0094
508 BOWEL MOVEMENT IRREGULARITY 72 0.0094
509 SEPTIC SHOCK 408 0.0094
510 LACERATION 88 0.0093
511 DECUBITUS ULCER 76 0.0093
512 ANAEMIA 1762 0.0092
513 MALNUTRITION 103 0.0092
514 BEDRIDDEN 121 0.0092
515 HAEMOGLOBIN ABNORMAL 59 0.0092
516 SARS-COV-2 TEST POSITIVE 121 0.0092
517 SLEEP APNOEA SYNDROME 174 0.0091
518 URINARY TRACT INFECTION 1552 0.0091
519 CORONAVIRUS INFECTION 60 0.0091
520 LIVER DISORDER 402 0.0091
521 INJECTION SITE INFLAMMATION 45 0.0090
522 NERVOUSNESS 471 0.0090
523 UNRESPONSIVE TO STIMULI 232 0.0090
524 HAEMORRHAGE 936 0.0089
525 EMPHYSEMA 90 0.0089
526 DIVERTICULITIS 247 0.0089
527 CONSTIPATION 1943 0.0089
528 HOT FLUSH 667 0.0088
529 LOWER LIMB FRACTURE 170 0.0088
530 PERIORBITAL SWELLING 50 0.0088
531 OCULAR DISCOMFORT 99 0.0088
532 DEVICE ADHESION ISSUE 135 0.0088
533 SCIATICA 140 0.0088
534 CARDIAC ARREST 725 0.0088
535 RECTAL HAEMORRHAGE 377 0.0088
536 HEPATOMEGALY 86 0.0087
537 JOINT INJURY 186 0.0087
538 HYPERTHYROIDISM 124 0.0086
539 LARGE INTESTINE POLYP 59 0.0085
540 PYREXIA 2944 0.0085
541 JOINT SWELLING 1026 0.0085
542 ASPIRATION 93 0.0085
543 ANKLE FRACTURE 131 0.0085
544 PAIN 5181 0.0084
545 SKIN WARM 49 0.0084
546 THERAPY INTERRUPTED 601 0.0084
547 ABDOMINAL PAIN 1954 0.0084
548 ORAL PAIN 188 0.0084
549 LIGAMENT SPRAIN 83 0.0084
550 MULTIPLE ORGAN DYSFUNCTION SYNDROME 237 0.0084
551 ABSCESS 133 0.0083
552 MUSCLE SPASMS 1529 0.0083
553 COVID-19 1460 0.0083
554 SKIN IRRITATION 380 0.0083
555 FOOD ALLERGY 64 0.0083
556 UPPER LIMB FRACTURE 165 0.0083
557 HYPOACUSIS 355 0.0082
558 THROAT TIGHTNESS 221 0.0082
559 HAEMORRHOIDS 159 0.0081
560 PRODUCT DOSE OMISSION 532 0.0081
561 TROPONIN INCREASED 62 0.0081
562 APPETITE DISORDER 54 0.0081
563 SMALL INTESTINAL OBSTRUCTION 100 0.0081
564 NO THERAPEUTIC RESPONSE 99 0.0081
565 WRIST FRACTURE 97 0.0081
566 SPINAL FRACTURE 162 0.0081
567 ATELECTASIS 78 0.0081
568 SCAB 92 0.0081
569 CHOLECYSTECTOMY 92 0.0080
570 SUDDEN DEATH 85 0.0080
571 INJECTION SITE INDURATION 104 0.0080
572 GASTROINTESTINAL PAIN 88 0.0080
573 CHOKING 156 0.0080
574 BLOOD DISORDER 64 0.0080
575 ORAL DISCOMFORT 111 0.0080
576 EYE INFECTION 90 0.0080
577 PSEUDOMONAS INFECTION 68 0.0079
578 THROMBOSIS 634 0.0079
579 TOOTH EXTRACTION 98 0.0079
580 BONE PAIN 461 0.0079
581 PULMONARY MASS 117 0.0078
582 PRODUCT COMMUNICATION ISSUE 69 0.0078
583 PRODUCT PREPARATION ISSUE 51 0.0078
584 RENAL FAILURE 1032 0.0078
585 DIARRHOEA HAEMORRHAGIC 72 0.0077
586 EXTRA DOSE ADMINISTERED 310 0.0076
587 ATRIAL SEPTAL DEFECT 64 0.0076
588 GASTROENTERITIS 110 0.0075
589 ARTHRALGIA 3130 0.0075
590 GROIN PAIN 66 0.0075
591 PHARYNGEAL SWELLING 73 0.0075
592 INFLUENZA LIKE ILLNESS 613 0.0074
593 LABORATORY TEST ABNORMAL 219 0.0074
594 PREMATURE DELIVERY 118 0.0074
595 CONTUSION 710 0.0074
596 TEMPERATURE INTOLERANCE 76 0.0074
597 RASH PRURITIC 398 0.0073
598 PRODUCT DOSE OMISSION ISSUE 2153 0.0073
599 SWELLING FACE 475 0.0073
600 ANXIETY 2067 0.0073
601 OLIGURIA 45 0.0072
602 POLLAKIURIA 301 0.0072
603 INSOMNIA 1917 0.0072
604 BODY TEMPERATURE INCREASED 146 0.0071
605 BRONCHIECTASIS 48 0.0071
606 HYPOKALAEMIA 328 0.0071
607 WOUND 198 0.0071
608 WOUND INFECTION 77 0.0070
609 SPINAL COMPRESSION FRACTURE 58 0.0070
610 DEFAECATION URGENCY 49 0.0070
611 SKIN DISCOLOURATION 321 0.0070
612 CONCUSSION 54 0.0070
613 GAIT INABILITY 233 0.0070
614 PANIC ATTACK 254 0.0070
615 HEPATIC ENCEPHALOPATHY 65 0.0070
616 HERPES ZOSTER 400 0.0070
617 NERVE COMPRESSION 64 0.0069
618 GINGIVAL PAIN 55 0.0069
619 CYSTITIS 219 0.0069
620 THYROID DISORDER 106 0.0069
621 BLOOD TEST ABNORMAL 96 0.0068
622 SPLENOMEGALY 80 0.0068
623 EYE HAEMORRHAGE 91 0.0068
624 INCOHERENT 44 0.0068
625 BACK DISORDER 110 0.0068
626 FACE OEDEMA 114 0.0068
627 INJECTION SITE ERYTHEMA 838 0.0067
628 PHOTOPHOBIA 127 0.0067
629 PRODUCT DOSE OMISSION IN ERROR 190 0.0067
630 CHOLELITHIASIS 219 0.0067
631 HAEMATOMA 173 0.0067
632 HEAVY MENSTRUAL BLEEDING 60 0.0067
633 EATING DISORDER 142 0.0067
634 SHOCK 153 0.0066
635 ARRHYTHMIA 315 0.0066
636 HYPERHIDROSIS 848 0.0066
637 HYSTERECTOMY 57 0.0066
638 POLYP 43 0.0066
639 ERYTHEMA 1349 0.0066
640 TENDERNESS 68 0.0065
641 LACRIMATION INCREASED 197 0.0065
642 POST PROCEDURAL INFECTION 53 0.0065
643 PANIC REACTION 47 0.0065
644 HAEMATOCRIT DECREASED 129 0.0065
645 INJECTION SITE PRURITUS 434 0.0065
646 EXTRASYSTOLES 45 0.0064
647 ESCHERICHIA INFECTION 53 0.0064
648 CHOLECYSTITIS 76 0.0064
649 ORTHOSTATIC HYPOTENSION 111 0.0064
650 PAROSMIA 48 0.0064
651 FUNGAL INFECTION 212 0.0064
652 ROAD TRAFFIC ACCIDENT 266 0.0064
653 LOWER GASTROINTESTINAL HAEMORRHAGE 47 0.0064
654 CARDIAC MURMUR 55 0.0064
655 SKIN ULCER 164 0.0063
656 EYE SWELLING 236 0.0063
657 APPLICATION SITE PRURITUS 143 0.0063
658 THIRST 112 0.0063
659 ARTHRITIS 493 0.0063
660 IRRITABLE BOWEL SYNDROME 134 0.0062
661 TREMOR 1035 0.0062
662 DEAFNESS 163 0.0062
663 LUNG INFILTRATION 55 0.0062
664 LYMPHOEDEMA 43 0.0062
665 CARDIO-RESPIRATORY ARREST 260 0.0062
666 AGEUSIA 155 0.0062
667 CAESAREAN SECTION 72 0.0062
668 UROSEPSIS 57 0.0062
669 NIGHT SWEATS 199 0.0062
670 PLATELET COUNT DECREASED 654 0.0061
671 TINNITUS 281 0.0061
672 INJECTION SITE RASH 187 0.0061
673 SCRATCH 64 0.0061
674 SENSATION OF FOREIGN BODY 51 0.0060
675 LOW BIRTH WEIGHT BABY 48 0.0060
676 COLON CANCER 90 0.0060
677 HEPATIC FAILURE 182 0.0060
678 DEPRESSED MOOD 319 0.0060
679 INTESTINAL OBSTRUCTION 227 0.0060
680 SHOCK HAEMORRHAGIC 49 0.0060
681 FOOT FRACTURE 114 0.0060
682 LIVE BIRTH 50 0.0060
683 SOMNOLENCE 1194 0.0059
684 ULCER 94 0.0059
685 ELECTROCARDIOGRAM ABNORMAL 46 0.0059
686 MUSCULAR WEAKNESS 665 0.0058
687 PRODUCT PHYSICAL ISSUE 118 0.0058
688 VISION BLURRED 803 0.0058
689 PREMATURE BABY 176 0.0058
690 BLADDER DISORDER 58 0.0058
691 PRODUCT CONTAINER ISSUE 50 0.0058
692 HIATUS HERNIA 75 0.0058
693 ACUTE RESPIRATORY DISTRESS SYNDROME 102 0.0058
694 RASH MACULAR 201 0.0057
695 MELAENA 126 0.0057
696 SALIVARY HYPERSECRETION 57 0.0057
697 PRODUCT ADMINISTRATION ERROR 115 0.0057
698 BURNING SENSATION 399 0.0057
699 INCORRECT DOSE ADMINISTERED BY DEVICE 149 0.0057
700 INJECTION SITE HAEMORRHAGE 454 0.0057
701 APPENDICITIS 53 0.0057
702 TACHYPNOEA 77 0.0057
703 FULL BLOOD COUNT DECREASED 114 0.0057
704 PHARYNGITIS 70 0.0056
705 VENTRICULAR TACHYCARDIA 93 0.0056
706 APPLICATION SITE IRRITATION 70 0.0056
707 LOCAL SWELLING 98 0.0056
708 ABNORMAL FAECES 46 0.0056
709 BLOOD URINE PRESENT 106 0.0056
710 INCONTINENCE 59 0.0056
711 OSTEOMYELITIS 101 0.0056
712 UPPER GASTROINTESTINAL HAEMORRHAGE 93 0.0055
713 INJECTION SITE DISCOMFORT 58 0.0055
714 LYMPHADENOPATHY 194 0.0055
715 TOOTH FRACTURE 60 0.0054
716 HYPOPHAGIA 139 0.0054
717 SCAR 93 0.0054
718 IMPAIRED GASTRIC EMPTYING 74 0.0054
719 OFF LABEL USE 4746 0.0054
720 LIVER FUNCTION TEST INCREASED 116 0.0054
721 MOBILITY DECREASED 387 0.0054
722 GAIT DISTURBANCE 1021 0.0053
723 MITRAL VALVE INCOMPETENCE 60 0.0053
724 RASH ERYTHEMATOUS 253 0.0053
725 INSURANCE ISSUE 80 0.0052
726 QUALITY OF LIFE DECREASED 70 0.0052
727 INCREASED TENDENCY TO BRUISE 48 0.0052
728 CATARACT 309 0.0052
729 GLOSSODYNIA 116 0.0052
730 HYPOAESTHESIA ORAL 78 0.0052
731 OCULAR HYPERAEMIA 244 0.0051
732 INJECTION SITE EXTRAVASATION 63 0.0051
733 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 245 0.0051
734 LIVER FUNCTION TEST ABNORMAL 148 0.0051
735 CEREBRAL HAEMORRHAGE 181 0.0051
736 GASTRITIS 133 0.0050
737 BLOOD GLUCOSE DECREASED 242 0.0050
738 BLOOD PRESSURE SYSTOLIC INCREASED 98 0.0050
739 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 904 0.0050
740 EYE PAIN 283 0.0050
741 DYSGEUSIA 372 0.0050
742 RENAL PAIN 53 0.0050
743 MEMORY IMPAIRMENT 686 0.0050
744 CIRCULATORY COLLAPSE 85 0.0050
745 BALANCE DISORDER 431 0.0050
746 HYPOAESTHESIA 745 0.0050
747 URINARY INCONTINENCE 147 0.0050
748 NEPHROLITHIASIS 227 0.0049
749 INCORRECT DOSE ADMINISTERED 1126 0.0049
750 CONFUSIONAL STATE 796 0.0049
751 DISCOMFORT 300 0.0049
752 LOWER RESPIRATORY TRACT INFECTION 223 0.0049
753 TOOTH DISORDER 109 0.0049
754 PULMONARY EMBOLISM 465 0.0049
755 BLOOD PRESSURE INCREASED 746 0.0049
756 ACUTE KIDNEY INJURY 743 0.0049
757 BLISTER 270 0.0048
758 BRAIN INJURY 48 0.0048
759 VITREOUS FLOATERS 47 0.0048
760 VISUAL IMPAIRMENT 591 0.0048
761 MICTURITION URGENCY 54 0.0047
762 PNEUMONIA ASPIRATION 118 0.0047
763 INJECTION SITE DISCOLOURATION 59 0.0047
764 VERTIGO 286 0.0047
765 IMPAIRED QUALITY OF LIFE 67 0.0047
766 ADVERSE EVENT 429 0.0047
767 LUNG NEOPLASM MALIGNANT 191 0.0046
768 PNEUMONITIS 126 0.0046
769 SKIN REACTION 65 0.0046
770 WHITE BLOOD CELL COUNT INCREASED 177 0.0046
771 DERMATITIS ALLERGIC 58 0.0046
772 BLOOD ALKALINE PHOSPHATASE INCREASED 114 0.0046
773 NEUROPATHY PERIPHERAL 436 0.0046
774 RESPIRATORY ARREST 126 0.0046
775 PARAESTHESIA 714 0.0045
776 ACCIDENT 54 0.0045
777 SKIN HAEMORRHAGE 67 0.0045
778 DYSSTASIA 131 0.0045
779 PRODUCT PREPARATION ERROR 92 0.0045
780 BLOOD CREATININE INCREASED 292 0.0045
781 HYPERTENSION 946 0.0045
782 CORONARY ARTERY OCCLUSION 61 0.0044
783 SKIN DISORDER 148 0.0044
784 CARPAL TUNNEL SYNDROME 62 0.0044
785 DEVICE DIFFICULT TO USE 293 0.0044
786 MUSCLE ATROPHY 56 0.0044
787 RASH 1897 0.0043
788 INABILITY TO AFFORD MEDICATION 43 0.0043
789 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 202 0.0043
790 INJECTION SITE SWELLING 330 0.0043
791 MASS 60 0.0043
792 MULTI-ORGAN FAILURE 74 0.0043
793 ENCEPHALOPATHY 105 0.0043
794 GASTRIC ULCER 81 0.0043
795 COAGULOPATHY 71 0.0043
796 BLOOD BILIRUBIN INCREASED 115 0.0043
797 RENAL IMPAIRMENT 356 0.0042
798 BREAST PAIN 45 0.0042
799 HAEMORRHAGE INTRACRANIAL 63 0.0042
800 SLEEP DISORDER 297 0.0042
801 MOOD ALTERED 114 0.0042
802 PRURITUS GENERALISED 90 0.0042
803 PARAESTHESIA ORAL 60 0.0042
804 PRURITUS 1593 0.0041
805 BLOOD UREA INCREASED 69 0.0041
806 TRANSIENT ISCHAEMIC ATTACK 139 0.0041
807 CHROMATURIA 93 0.0041
808 HIP ARTHROPLASTY 63 0.0041
809 DISORIENTATION 163 0.0041
810 EXPOSURE VIA SKIN CONTACT 106 0.0041
811 PANCREATITIS 216 0.0041
812 INJECTION SITE WARMTH 84 0.0041
813 DENTAL CARIES 45 0.0041
814 RED BLOOD CELL COUNT DECREASED 116 0.0041
815 PHOTOSENSITIVITY REACTION 67 0.0041
816 HYPERSENSITIVITY 751 0.0040
817 ABDOMINAL PAIN LOWER 102 0.0040
818 OESOPHAGITIS 44 0.0040
819 DYSURIA 147 0.0040
820 RESTLESSNESS 146 0.0040
821 MACULAR DEGENERATION 47 0.0039
822 COLITIS 149 0.0039
823 APPLICATION SITE RASH 54 0.0039
824 SEIZURE 449 0.0039
825 DYSPHAGIA 366 0.0039
826 APPLICATION SITE ERYTHEMA 101 0.0038
827 INJECTION SITE PAIN 1179 0.0038
828 PROCEDURAL PAIN 106 0.0038
829 JOINT STIFFNESS 100 0.0038
830 THROMBOCYTOPENIA 426 0.0038
831 SINUS TACHYCARDIA 54 0.0038
832 PREGNANCY 76 0.0038
833 RASH GENERALISED 98 0.0038
834 HYPONATRAEMIA 212 0.0038
835 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 64 0.0037
836 INTENTIONAL PRODUCT USE ISSUE 322 0.0037
837 MENTAL IMPAIRMENT 89 0.0037
838 NEOPLASM MALIGNANT 245 0.0037
839 MENORRHAGIA 72 0.0037
840 IMPAIRED HEALING 120 0.0037
841 DEVICE DEFECTIVE 63 0.0036
842 INCREASED APPETITE 69 0.0036
843 ANGINA PECTORIS 103 0.0036
844 SURGERY 209 0.0036
845 CYST 44 0.0035
846 ASPARTATE AMINOTRANSFERASE INCREASED 188 0.0035
847 ACTIVITIES OF DAILY LIVING IMPAIRED 70 0.0035
848 NODULE 46 0.0035
849 RASH PAPULAR 79 0.0035
850 ROTATOR CUFF SYNDROME 45 0.0035
851 AMNESIA 225 0.0035
852 PERICARDITIS 58 0.0034
853 CEREBROVASCULAR ACCIDENT 583 0.0034
854 EYE DISORDER 113 0.0034
855 LIP SWELLING 114 0.0034
856 BLOOD GLUCOSE ABNORMAL 63 0.0034
857 VAGINAL HAEMORRHAGE 148 0.0034
858 THERAPEUTIC RESPONSE DECREASED 206 0.0034
859 IRRITABILITY 204 0.0034
860 PHARYNGEAL OEDEMA 52 0.0034
861 FEMUR FRACTURE 104 0.0034
862 BRADYCARDIA 177 0.0033
863 ASTHMA 376 0.0033
864 MYOCARDIAL INFARCTION 572 0.0033
865 DIPLOPIA 85 0.0033
866 ADVERSE DRUG REACTION 292 0.0032
867 SPEECH DISORDER 170 0.0032
868 END STAGE RENAL DISEASE 59 0.0032
869 ACUTE MYOCARDIAL INFARCTION 94 0.0032
870 FIBROMYALGIA 77 0.0032
871 HYPERKALAEMIA 111 0.0032
872 CRYING 113 0.0031
873 DEVICE DELIVERY SYSTEM ISSUE 85 0.0031
874 EYE PRURITUS 104 0.0031
875 NEEDLE ISSUE 90 0.0031
876 INFLAMMATION 159 0.0031
877 EXPOSURE DURING PREGNANCY 191 0.0031
878 URTICARIA 510 0.0030
879 ANOSMIA 44 0.0030
880 THINKING ABNORMAL 56 0.0030
881 INTERVERTEBRAL DISC PROTRUSION 65 0.0030
882 MATERNAL EXPOSURE DURING PREGNANCY 263 0.0029
883 DRUG ADMINISTRATION ERROR 90 0.0029
884 MUSCLE TWITCHING 67 0.0029
885 DEMENTIA 81 0.0029
886 DEPRESSION 656 0.0029
887 MENTAL DISORDER 125 0.0029
888 ORAL HERPES 55 0.0028
889 GLAUCOMA 54 0.0028
890 ALANINE AMINOTRANSFERASE INCREASED 172 0.0028
891 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 198 0.0028
892 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 560 0.0028
893 SYRINGE ISSUE 48 0.0027
894 STOMATITIS 161 0.0027
895 CONJUNCTIVITIS 49 0.0026
896 MIDDLE INSOMNIA 49 0.0026
897 MUSCULOSKELETAL STIFFNESS 229 0.0026
898 DYSARTHRIA 96 0.0025
899 ABASIA 63 0.0025
900 RENAL FAILURE ACUTE 108 0.0025
901 LEUKOCYTOSIS 46 0.0025
902 DRY SKIN 337 0.0025
903 APPLICATION SITE PAIN 55 0.0025
904 ILL-DEFINED DISORDER 151 0.0025
905 ARTHROPATHY 138 0.0025
906 DERMATITIS 52 0.0025
907 FRACTURE 46 0.0024
908 BLINDNESS 99 0.0024
909 EMOTIONAL DISORDER 74 0.0024
910 UNDERDOSE 175 0.0024
911 DIABETES MELLITUS 182 0.0024
912 HEPATIC CANCER 57 0.0024
913 DRUG ERUPTION 42 0.0024
914 OSTEOPOROSIS 97 0.0024
915 PAIN OF SKIN 60 0.0022
916 HEPATIC FUNCTION ABNORMAL 83 0.0022
917 EYE IRRITATION 128 0.0022
918 HEPATIC ENZYME INCREASED 150 0.0022
919 FEAR 59 0.0022
920 URINARY RETENTION 73 0.0022
921 SKIN LESION 60 0.0022
922 OVERDOSE 469 0.0022
923 PRODUCT AVAILABILITY ISSUE 49 0.0021
924 DISTURBANCE IN ATTENTION 116 0.0021
925 CONTRAINDICATED PRODUCT ADMINISTERED 65 0.0021
926 HYPOGLYCAEMIA 104 0.0021
927 HAEMATURIA 73 0.0021
928 ACCIDENTAL EXPOSURE TO PRODUCT 219 0.0021
929 DRY EYE 106 0.0021
930 DEEP VEIN THROMBOSIS 135 0.0021
931 PERITONITIS 43 0.0021
932 DELIRIUM 70 0.0020
933 CORONARY ARTERY DISEASE 61 0.0020
934 SKIN CANCER 43 0.0020
935 AGITATION 145 0.0020
936 EXPIRED PRODUCT ADMINISTERED 65 0.0020
937 SWOLLEN TONGUE 61 0.0020
938 HYPOTHYROIDISM 62 0.0019
939 APHASIA 58 0.0019
940 INJECTION SITE REACTION 132 0.0019
941 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 136 0.0019
942 ALOPECIA 370 0.0019
943 SKIN EXFOLIATION 155 0.0018
944 ECZEMA 92 0.0018
945 HALLUCINATION 132 0.0017
946 THERAPEUTIC RESPONSE UNEXPECTED 78 0.0017
947 FOETAL EXPOSURE DURING PREGNANCY 141 0.0017
948 BLOOD GLUCOSE INCREASED 316 0.0017
949 COMA 79 0.0017
950 CHRONIC KIDNEY DISEASE 126 0.0017
951 DYSKINESIA 67 0.0016
952 RHEUMATOID ARTHRITIS 186 0.0016
953 JAUNDICE 44 0.0016
954 PRODUCT ADHESION ISSUE 58 0.0016
955 INJECTION SITE MASS 60 0.0016
956 MOVEMENT DISORDER 52 0.0016
957 OSTEOARTHRITIS 68 0.0016
958 COLITIS ULCERATIVE 71 0.0016
959 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 86 0.0016
960 INJECTION SITE BRUISING 125 0.0016
961 HYPERGLYCAEMIA 57 0.0016
962 ABNORMAL DREAMS 43 0.0016
963 PANCYTOPENIA 86 0.0015
964 DRUG INTERACTION 244 0.0015
965 SKIN BURNING SENSATION 110 0.0015
966 WHITE BLOOD CELL COUNT DECREASED 157 0.0014
967 DRUG INEFFECTIVE 1904 0.0014
968 MEDICATION ERROR 79 0.0014
969 DEPRESSED LEVEL OF CONSCIOUSNESS 56 0.0014
970 PRODUCT USE IN UNAPPROVED INDICATION 346 0.0014
971 NERVOUS SYSTEM DISORDER 43 0.0014
972 COGNITIVE DISORDER 63 0.0013
973 NIGHTMARE 46 0.0013
974 INJURY 92 0.0013
975 C-REACTIVE PROTEIN INCREASED 47 0.0013
976 BREAST CANCER 108 0.0012
977 CONVULSION 64 0.0011
978 ANGIOEDEMA 49 0.0011
979 ABNORMAL BEHAVIOUR 43 0.0011
980 ACNE 76 0.0010
981 PRODUCT QUALITY ISSUE 132 0.0010
982 SUICIDAL IDEATION 83 0.0009
983 TREATMENT FAILURE 71 0.0009
984 PRODUCT SUBSTITUTION ISSUE 46 0.0008
985 ANAPHYLACTIC REACTION 44 0.0008
986 INTENTIONAL PRODUCT MISUSE 69 0.0008
987 DRUG ABUSE 59 0.0007
988 PRODUCT STORAGE ERROR 57 0.0007
989 TOXICITY TO VARIOUS AGENTS 108 0.0006
990 NO ADVERSE EVENT 113 0.0006
991 EMOTIONAL DISTRESS 75 0.0006
992 DRUG DOSE OMISSION BY DEVICE 46 0.0006
993 DRUG WITHDRAWAL SYNDROME 51 0.0006
994 PSORIASIS 54 0.0004